Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
630 | 9614 | 41.1 | 83% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
2255 | 4236 | PTP1B//PROTEIN TYROSINE PHOSPHATASE//PRL 3 |
2325 | 4032 | NOONAN SYNDROME//COSTELLO SYNDROME//THROMBOSPONDIN 1 |
3304 | 1346 | SPARC//GROWTH DIFFERENTIATION FACTOR 15//GDF 15 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOONAN SYNDROME | Author keyword | 474 | 78% | 3% | 314 |
2 | COSTELLO SYNDROME | Author keyword | 271 | 88% | 1% | 127 |
3 | PROTEIN TYROSINE PHOSPHATASE | Author keyword | 182 | 41% | 4% | 345 |
4 | THROMBOSPONDIN 1 | Author keyword | 174 | 55% | 2% | 219 |
5 | SPARC | Author keyword | 173 | 55% | 2% | 216 |
6 | PTPN11 | Author keyword | 152 | 76% | 1% | 107 |
7 | THROMBOSPONDIN | Author keyword | 138 | 49% | 2% | 204 |
8 | PTP1B | Author keyword | 135 | 59% | 2% | 153 |
9 | PRL 3 | Author keyword | 116 | 88% | 1% | 56 |
10 | SHP 2 | Author keyword | 115 | 50% | 2% | 166 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOONAN SYNDROME | 474 | 78% | 3% | 314 | Search NOONAN+SYNDROME | Search NOONAN+SYNDROME |
2 | COSTELLO SYNDROME | 271 | 88% | 1% | 127 | Search COSTELLO+SYNDROME | Search COSTELLO+SYNDROME |
3 | PROTEIN TYROSINE PHOSPHATASE | 182 | 41% | 4% | 345 | Search PROTEIN+TYROSINE+PHOSPHATASE | Search PROTEIN+TYROSINE+PHOSPHATASE |
4 | THROMBOSPONDIN 1 | 174 | 55% | 2% | 219 | Search THROMBOSPONDIN+1 | Search THROMBOSPONDIN+1 |
5 | SPARC | 173 | 55% | 2% | 216 | Search SPARC | Search SPARC |
6 | PTPN11 | 152 | 76% | 1% | 107 | Search PTPN11 | Search PTPN11 |
7 | THROMBOSPONDIN | 138 | 49% | 2% | 204 | Search THROMBOSPONDIN | Search THROMBOSPONDIN |
8 | PTP1B | 135 | 59% | 2% | 153 | Search PTP1B | Search PTP1B |
9 | PRL 3 | 116 | 88% | 1% | 56 | Search PRL+3 | Search PRL+3 |
10 | SHP 2 | 115 | 50% | 2% | 166 | Search SHP+2 | Search SHP+2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTEGRIN ASSOCIATED PROTEIN | 268 | 67% | 3% | 245 |
2 | PTPN11 MUTATIONS | 199 | 81% | 1% | 121 |
3 | PLATELET THROMBOSPONDIN | 188 | 76% | 1% | 132 |
4 | PROTEIN TYROSINE PHOSPHATASE | 147 | 21% | 6% | 618 |
5 | SH2 CONTAINING PHOSPHOTYROSINE PHOSPHATASE | 136 | 64% | 1% | 133 |
6 | NOONAN SYNDROME | 129 | 43% | 2% | 231 |
7 | FACIO CUTANEOUS SYNDROME | 124 | 60% | 1% | 134 |
8 | SECRETE THROMBOSPONDIN | 123 | 91% | 1% | 51 |
9 | MIC 1 | 122 | 88% | 1% | 58 |
10 | MACROPHAGE INHIBITORY CYTOKINE 1 | 118 | 65% | 1% | 112 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Interaction Between Signal Regulatory Protein Alpha (SIRP alpha) and CD47: Structure, Function, and Therapeutic Target | 2014 | 18 | 148 | 74% |
Inside the human cancer tyrosine phosphatome | 2011 | 133 | 182 | 64% |
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery | 2007 | 238 | 69 | 90% |
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling | 2003 | 596 | 92 | 67% |
Protein tyrosine phosphatases: from genes, to function, to disease | 2006 | 618 | 126 | 44% |
Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines | 2010 | 91 | 110 | 95% |
The RASopathies | 2013 | 47 | 63 | 57% |
Protein tyrosine phosphatases in the human genome | 2004 | 929 | 69 | 32% |
Protein-tyrosine phosphatases and cancer | 2006 | 283 | 154 | 72% |
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation | 2009 | 206 | 49 | 47% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOSIGNAL SCI | 75 | 83% | 0.4% | 43 |
2 | BARBARA JANE LEVY MOL NEUROONCOL | 15 | 71% | 0.1% | 12 |
3 | SPECIAL HEMATOL | 14 | 51% | 0.2% | 20 |
4 | HOPE HEART PROGRAM | 14 | 32% | 0.4% | 37 |
5 | BIOPATHOL IMAGING DIAGNOST | 13 | 39% | 0.3% | 27 |
6 | SECT HISTOL CELL BIOL | 11 | 38% | 0.2% | 23 |
7 | EDMOND H FI ER SIGNAL TRANSDUCT | 11 | 40% | 0.2% | 21 |
8 | CHEM GENOM CORE IL | 10 | 57% | 0.1% | 12 |
9 | BIOPATHOL HUMAN POPULAT ENVIRONM PATHOL | 9 | 67% | 0.1% | 8 |
10 | DIPARTIMENTO BIOL CELLULARE NEUROSCI | 8 | 24% | 0.3% | 28 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000004729 | HER 2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA |
2 | 0.0000002789 | CD44//HYALURONAN//INTEGRIN |
3 | 0.0000002550 | HEPARANASE//MIDKINE//HEPARAN SULFATE |
4 | 0.0000002471 | TRANSCRIPTION FACTOR//ETS 1//C JUN |
5 | 0.0000002344 | HYPOPHOSPHATASIA//ALKALINE PHOSPHATASE//TISSUE NONSPECIFIC ALKALINE PHOSPHATASE |
6 | 0.0000002124 | PROSTATE CANCER//PROSTATIC NEOPLASMS//RADICAL PROSTATECTOMY |
7 | 0.0000001979 | POMPE DISEASE//PROTEIN KINASE CK2//GLYCOGEN STORAGE DISEASE TYPE II |
8 | 0.0000001904 | OPHTHALMOLOGY//RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES//OPHTHALMOL |
9 | 0.0000001765 | EXPERIMENTAL HEMATOLOGY//THROMBOPOIETIN//JOURNAL OF INTERFERON RESEARCH |
10 | 0.0000001686 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//DROSOPHILA |